Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Unethical Behavior
NCT02361177Phase 1Withdrawn
- Sponsor
- University of Texas at Austin
- Start
- Jan 2016
- Primary completion
- Apr 2016
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in antisocial personality disorder (ASPD) (2 arms), sponsored by University of Texas at Austin. Primary endpoint: Unethical behavior at 130 minutes. Planned start Jan 2016; status: withdrawn.
02
Drugs
oxytocin nasal spray
03
Conditions
antisocial personality disorder (ASPD)
Beyond the preview
Go deeper on NCT02361177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02361177.